Antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
US7495068B2 · kind B2 · utility
1Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2004 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Aug 7, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian kringle 5 fragments and kringle 5 fusion proteins are disclosed as a compounds for treating angiogenic diseases. Methods and compositions for inhibiting angiogenic diseases are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.